All lobbying filings

Splitoak Strategies LLC

Splitoak Strategies LLC filed a Q2 report for Alkermes, Inc. on August 3, 2026, reporting $60,000 in lobbying income.

Lobbying for Alkermes, Inc. · Global biopharmaceutical company

As filed: SPLITOAK STRATEGIES LLC for ALKERMES, INC.

All filings by Splitoak Strategies LLC · Everything Alkermes, Inc. has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Aug 3, 2026

Income

$60,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 1

SARAH KUEHL EGGE

Previously held: Sarah: 1998-2000 Legislative Assistant to Senator Bob Kerrey; 2001-2012 Senior Budget Analyst for Democratic Staff of the Senate Budget Committee (Kent Conrad); Fall 2011, Deputy Staff Director, Joint Select Committee for Deficit Reduction

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Medicare/Medicaid

Advance the use and funding of FDA-approved medicines to treat serious mental illness; protecting patient access to mental health medications in public programs

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.